Abstract
The effects of Spirulina maxima (SMNJU.02) on pharmacological and toxicological tests in mice and rats were investigated. S. maxima (SMNJU.02) dose-dependently enhanced the immunological functions and reduced the level of serum lipids, without producing adverse effects. When mice were orally treated with S. maxima (SMNJU.02) at a concentration ranging from 0.5–1.0 g/kg body weight, significant differences in the rate of carbon clearance and foot hone plate swelling were observed, and the humoral immunity was significantly increased. The white blood corpuscle (WBC) count, the level of DNA in bone marrow, the coefficient of spleen, and the number of colony forming unit of spleen surface in the mice with leucocytopenia caused by cyclophosphamide or 60Co- γ were significantly increased when SMNJU.02 (1.0 g/kg body weight) was taken orally. After the treatment with SMNJU.02 (0. 5–1. 0 g/kg body weight), the arteriosclerosis indexes, the levels of total cholesterol (TC) and triglyceride (TG) in the serum of hyperlipaemia rats induced by hyperliposis food were lower, but the serum high density lipoprotein (HDL) level was higher than in rats without SMNJU.02 in their diet. The SMNJU.02 (1.5–4.5 g/kg body weight) ingestion had no effect on behavior, food and water intake, growth or survival after 90-day treatment and the terminal values in hematology and clinical chemistry did not reveal significant differences compared with the control group. These results support the potential health protective role of SMNJU.02.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Becker, E. W. and Venkataraman, L. V. (1984) Production and utilization of the blue green algae Spirulina in India. Biomass 4, 105–125.
Becker, E.W., Jakober, B., Luft, D. and Schmulling, R.M. (1986) Clinical and biochemical evaluations of the alga Spirulina with regard to its application in the treatment of obesity .A double-blind crossover study. Nutr. Rep Int. 33, 565–572.
Belay, A., Kato, T. and Ota, Y. (1997) Spriulina (Arthospira): potential application as an animal feed supplement. J. Appl. Phycol. 18, 303–311.
Chabner, B.A., Allegra, C.J., Curt, G.A. and Calabresi, P. (1996) Antineoplastic agents, in J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, and A.G. Gilman (eds), Goodman And Gilman’s The Pharmacological Basis of Therapeutics, McGraw-Hill, New York, pp. 1233–1287.
Chamorro, G. and Salazar, M., (1990) Estudio teratogénico de Spirulina en ratón. Archivos Latinoamericanos de Nutrición 40, 86–94.
Chamorro, G., Herrera, G., Salazar, M., Salazar, S. and Ulloa,V. (1988) Etude de la toxicité chronique de la Spirulina chez le rat. Médicine et Nutrition 24, 104–106.
Chamorro, G., Salazar, M. and Pages, N. (1996) Lethal study of Spirulina maxima in male and female rats after short-term feeding. Phytotherapy Res. 10, 28–32.
Ciferri, O. (1983) Spirulina, the edible microorganism. Microbiol. Review 47, 551–578.
Davis, L. and Kuttan, G. (1998) Suppressive effect of cyclophosphamide-induced toxicity by Withania somnifera extract in mice. J. Ethnopharmacol. 62, 209–214.
Dillon, J.C. and Phan, P.A. (1993) Spirulina as a source of protein in human nutrition. Bulletin de l’Institut Océanographique 12, 103–107.
Dixit, V.P., Varma, M., Mathur, N.T., Mathur, R. and Sharmam, S. (1992) Hypocholesterolemic and antiatherosclerotic effects of solasodine (C27H42O2N) in cholesterol-fed rabbits. Phytotherapy Res. 6, 270–273.
Derivera, C.G., Mirandazamora, R., Diazzagoya, J.C. and Juárezoropeza, M.A. (1993). Preventive effect of Spirulina-maxima on the fatty liver induced by a fructose-rich diet in the rat, a preliminary-report. Life Sciences 53, 57–61.
Hayashi, O., Katoh, T. and Okuwarki, Y. (1994) Enhancemennt of antibody production in mice by dietary Spirulina platensis. J. Nutr Science Vitaminol 40, 431–441.
Harris, J.E. and Hersh, E.M. (1968) The effect of 1-beta-D-arabinofiuranosylcytosine on the immune response of mice to sheep red blood cells. Cancer Res. 28, 2432–2436.
Iwata, K., Inayama, T. and Kato, T. (1990) Effect of Spirulina platensis on plasma lipoprotein lipase activity in fructose-induced hyperlipidemic rats. J. Nutr Science Vitaminol 36, 165–171.
Kay, R.A. (1991) Microalgae as food and supplement. Critical Rev. in Food Science and Nutr. 30, 555–573.
Krishnakumari, M. K., Ramesh, H.P. and Venkataraman, L. V. (1982) Food safety evaluation: acute oral and dermal effects of the algae Senedesmnus acutus and Spirulina platensis on albino rats. J. Food Protection 44, 934–935 .
Paredes-Carbajal, M.C., Torres-Durán, P.V, Diaz-Zagoya, J.C., Mascher, D. and Juárez-Oropeza, M.A. (1997) Effects of dietary Spirulina maxima on endothelium dependent vasomoter responses of rat arotic rings. Life Sciences 61, 211–219.
Qishen, P., Guo, B.J. and Kolman, A. (1989) Radioprotective effect of extract from Spirulina platensis in mouse bone marrow cells studied by using the micronucleus test. Toxicol. Lett. 48,165–169.
Qureshi, M. A. and Ali, R. A. (1996) Spirulina platensis exposure enhances macrophage phagocytic function in cats. Immunopharmacol. Immunotoxicity 18, 457–463.
Qureshi, M.A., Garlich, J.D. and Kidd, M.T. (1996). Dietary Spirulina platensis enhances humoral and cellmediated immune function in chickens. Immunopharmacol. Immunotoxicol. 18, 465–476.
Salazar, M., Chamorro, G.A., Salazar, S. and Steele, C.E. (1996) Effect of Spirulina maxima consumption on reproduction and peri-and postnatal development in rats. Food Chemical Toxicol. 34, 353–359.
Schwartz, J. and Shklar, G. (1988) Prevention of experimental oral cancer by extracts of Spirulina-Dunaliella algae. Nutritional Cancer 11, 127–134.
Torres-Durán, P.V., Miranda-Zamora, R., Paredes-Carbajal, M.C., Mascher, D., Diaz-Zagoya, J.C. and JuárezOropza, M.A. (1998) Spirulina maxima prevents induction of fatty liver by carbon terachloride in the rat. Biochem. Mol. Biol. Int. 44, 787–793.
Tranquille, N., Emeis, J.J., de Chambure, D., Binot, R. and Tamponnet, C. (1994) Spirulina acceptability trials in rats. a study for the ‘Melissa’ life-support system. Advances in Space Research 14, 1167–1170.
Wardman, P. and Ross, A.B. (1991) Radiation chemistry literature compilations: their wider value in free radical research. Free Radio. Biol. Med. 10, 243–247.
Yoshino, Y., Hirai, Y., Takahashi, H., Yamamoto, N. and Yamazaki, N. (1980) The chronic intoxication test on product fed to Wistar-strain rats. Jap. J. Nutr. 38, 221–225.
Ziauddin M., Phansalkar, N., Patki, P., Diwanay, S. and Patwardhan, B. (1996) Studies on the immunomodulatory effects of Ashwagandha. J. Ethnopharmacol. 50, 69–76.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Liu, Z.L., Cao, D.H. (2001). Studies of the Pharmacology and Toxicology of Spirulina Maxima (SMNJU.02). In: Chen, F., Jiang, Y. (eds) Algae and their Biotechnological Potential. Springer, Dordrecht. https://doi.org/10.1007/978-94-015-9835-4_18
Download citation
DOI: https://doi.org/10.1007/978-94-015-9835-4_18
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-5886-7
Online ISBN: 978-94-015-9835-4
eBook Packages: Springer Book Archive